Home LiteratureArticle Details
PMID: 18544706 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.

Diabetes ·Vol. 57 ·No. 9 ·2008-09-00 ·Pages 2480-7

Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, Hietala K, Kyllönen L, Kytö J, Rosengård-Bärlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, Ala-Korpela M, Groop PH, FinnDiane Study Group

Abstract

Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, the goal was to reveal previously undetected association patterns between clinical diagnoses and biochemistry in the FinnDiane dataset. At baseline, clinical records, serum, and 24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes were collected. The data were analyzed by the self-organizing map, which is an unsupervised pattern recognition algorithm that produces a two-dimensional layout of the patients based on their multivariate biochemical profiles. At follow-up, the results were compared against all-cause mortality during 6.5 years (295 deaths). The highest mortality was associated with advanced kidney disease. Other risk factors included 1) a profile of insulin resistance, abdominal obesity, high cholesterol, triglycerides, and low HDL(2) cholesterol, and 2) high adiponectin and high LDL cholesterol for older patients. The highest population-adjusted risk of death was 10.1-fold (95% CI 7.3-13.1) for men and 10.7-fold (7.9-13.7) for women. Nonsignificant risk was observed for a profile with good glycemic control and high HDL(2) cholesterol and for a low cholesterol profile with a short diabetes duration. The self-organizing map analysis enabled detailed risk estimates, described the associations between known risk factors and complications, and uncovered statistical patterns difficult to detect by classical methods. The results also suggest that diabetes per se, without an adverse metabolic phenotype, does not contribute to increased mortality.

MeSH Terms
Abdominal Fat Adult Diabetes Mellitus, Type 1/genetics,metabolism,mortality Diabetic Angiopathies/genetics,metabolism,mortality Energy Metabolism Female Finland/epidemiology Humans Insulin Resistance Kidney Diseases/genetics,metabolism,mortality Male Medical Records Metabolic Syndrome/genetics,metabolism,mortality Middle Aged Multivariate Analysis Obesity/genetics,metabolism,mortality Phenotype Risk Factors
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Mäkinen Ville-Petteri
Department of Biomedical Engineering and Computational Science, Helsinki University of Technology, Helsinki, Finland.
Forsblom Carol
Thorn Lena M
Wadén Johan
Gordin Daniel
Heikkilä Outi
Hietala Kustaa
Kyllönen Laura
Kytö Janne
Rosengård-Bärlund Milla
Saraheimo Markku
Tolonen Nina
Parkkonen Maija
Kaski Kimmo
Ala-Korpela Mika
Groop Per-Henrik
FinnDiane Study Group
Investigators
302 investigators, click to expand
Koivula Sirpa
Uggeldahl Tarja
Nikkola Anita
Ritola Eila
Oukko-Ruponen Eija
Saarinen Hanna
Kataja-Tuomola Merja
Niska Marjatta
Lyytinen Anne
Raumavirta-Koivisto Satu
Kovanen Marjo
Ensala Tuula
Hussi Esko
Toivonen Jukka
Matikainen Tuula
Vanamo Raimo
Hasu Helga
Hentunen Päivi
Lagerstam Jukka
Pohjola Kari
Silvennoinen Heli
Simonen Tiina
Kari Hennele
Kaprio Anja
Rantaeskola Birgitta
Haaga Jari
Kääriäinen Pirjo
Pietiläinen Anna-Liisa
Saraheimo Markku
Wickström Kerstin
Nikkanen Paula
Salmi Pirkko
Klemetti Sisko
Nyandoto Teija
Rontu Eija
Satuli-Autere Susanna
Toivanen Eija
Hyytiäinen Jaana
Laitinen Tuula
Lagerstam Jukka
Aranko Suvimarja
Leppälä Tarmo
Ervasti Suvi
Kauppinen-Mäkelin Ritva
Kuusisto Arto
Nikkilä Katriina
Pekkonen Leena
Nuorva Kirsti
Tiihonen Marja
Kinnunen Tuula
Nikulainen Liisa
Salokangas Tuula
Jokelainen Silja
Kemppainen Paula
Mankinen Anna-Maria
Sankari Marja
Myllykangas Tuula
Kinnunen Pirjo
Orvola Anja
Salonen Tapani
Vähänen Annukka
Stuckey Helene
Suominen Paula
Anderson Stefan
Asplund Beatrice
Byskata Ulrika
Byskata Ingvor
Virkkala Toini
Liedes Päivi
Forslund Terje
Koskiaho Pirkko
Laukkanen Marianne
Saltevo Juha
Tiihonen Marja
Koskiaho Pirkko
Halonen Anne
Koistinen Arvo
Leppänen Esa
Koski Anna-Mari
Lappalainen Anja
Liimatainen Maisa
Santaholma Jaana
Aimolahti Ari
Kärki Maarit
Lehtimäki Maija
Uhlenius Nina
Huovinen Eeva
Ilkka Veikko
Pälikkö-Kontinen Eeva
Vanhanen Annika
Koskinen Erkki
Borgman Anna
Siitonen Taimi
Huttunen Erja
Ikäheimo Risto
Kiljander Päivi
Laakso Markku
Lakka Timo
Moilanen Leena
Niskanen Leo
Tuovinen Ulla
Vauhkonen Ilkka
Voutilainen Erkki
Karhapää Pauli
Kekäläinen Päivi
Lampainen Erkki
Isopoussu Erja
Kääriäinen Tapio
Vierimaa Eero
Kilkki Esa
Riihelä Liisa
Riihelä Mare
Ryysy Leena
Paldanius Reino
Meriläinen Taina
Poukka Paula
Tikkanen Tuula
Savolainen Riitta
Mäkelä Aulikki
Tanner Marjukka
Behm Eija
Nyländen Pirkko
Laukkanen Hilkka
Myllykoski Pirjo
Jousmaa Inge-Maj
Rinne Jukka
Linkola Pirjo
Pulli Irja
Severinkangas Sirkka
Tulokas Timo
Hyvärinen Liisa
Granlund Tuula
Saari Mikko
Salonen Tuula
Tähtinen Reija
Eloranta Pirjo
Mäkelä Arja
Kalliomäki Tarja
Koskelainen Juha
Nikkanen Riitta
Salonen Vesa
Savolainen Niilo
Sulonen Hannu
Valtonen Eija
Lanki Helena
Moilanen Seija
Tilly-Kiesi Marju
Hänninen Anne-Mirjami
Pirttiniemi Ismo
Gynther Anita
Salminen Maarit
Vänttinen Tuomo
Honkasalo Mikko
Miettinen Marko
Nurminen Päivi
Jokelainen Elina
Jylkkä Pirkko-Liisa
Kaarlela Elsi
Vuolaspuro Jari
Häkkinen Rauni
Hiltunen Liisa
Keinänen-Kiukaanniemi Sirkka
Haapamäki Hannu
Hämäläinen Satu
Helanterä Antero
Ilvesmäki Vesa
Miettinen Hilkka
Tick-Sinkkilä Tarja
Welling Leena
Mäkinen Kirsti
Sopanen Päivi
Tamminen Mari
Taskinen Markku
Holmbäck Maj-Len
Isomaa Bo
Sarelin Leena
Hyttinen Laura
Kekäläinen Päivi
Pietarinen Maija
Rissanen Anneli
Laitinen Risto
Turtola Hannu
Henttula Ulla Maija
Merensalo Pirjo
Sävelä Kirsi
Viitala Terttu
Ahonen Päivi
Johansson Heidi
Rämö Sirkka
Rask Bjarne
Kallion Marjatta
Holma Anne
Honkala Matti
Tuomivaara Aino
Vainionpää Riitta
Laine Kaisa
Salminen Taru
Ketola Paula
Saarinen Kaisa
Aalto Pirkko
Lanni Marja
Laitaharju Irmeli
Immonen Eija
Juurinen Leena
Lapinleimu Jouni
Rautio Pirkko
Virtanen Merja
Alanko Anita
Asola Markku
Pääkkönen Paavo
Pentti Marjo
Rautavirta Marja
Kunelius Pertti
Mannila Sirkku
Pulli Tuula
Sallinen Päivi
Toivanen Eija
Valtonen Helena
Vartia Aarne
Korpi-Hyövälti Eeva
Latvala Terhikki
Leijala Esko
Nyrhilä Tarja
Rinne Jukka
Jousma Inge-Maj
Alarotu Pekka
Calonius Liisa
Gummerus Seppo
Helin Paula
Kaitala Tarja
Kirkkopelto-Jokinen Helena
Kujansuu Eila
Niskanen Taru
Vadén Atte
Saaristo Timo
Kuortti Marjo
Kallio Arja
Ala-Houhala Ilpo
Kuningas Tuula
Lampinen Paula
Määttä Marita
Oksala Heikki
Oksanen Tuija
Salonen Kristiina
Tulokas Sirkku
Tauriainen Hilkka
Petlin Leena
Savolainen Liisa
Kivelä Tiina
Artukka Anne
Hämäläinen Irmeli
Kokkila Päivi
Sorvari Lea
Vähätalo Markku
Virtamo Hille
Breitholz Kaija
Eskola Raija
Metsärinne Kaj
Neva Riikka
Pietilä Ulla
Saarinen Pirjo
Tuominen Riitta
Asola Markku
Ayräpää Sari
Sopanen Päivi
Mäkinen Kirsti
Bergkulla Stig
Hautamäki Ulla
Myllyniemi Vivi-Ann
Rusk Irma
Immonen Terhi
Ojanen Seppo
Rautiainen Maisa
Valtonen Eija
Ylönen Hannu
Isomäki Irma
Mustaniemi Leena
Tapiolinna-Mäkela Merja
Kroneld Riitta
Vahtola Jaana
Toivonen Riitta
Ahonen Raila
Ivaska-Suomela Marja
Jauhiainen Anu
Kultti Sari
Kiviniemi Pirjo
Laine Merja
Pellonpää Tiina
Puranen Riitta
Airas Anne
Laakso Jukka
Eerola Matti
Jatkola Eeva
Lönnblad Riitta
Mäkelä Jari
Malm Anita
Rautamo Elli
Granlund Hans
Johnsson Ann-Christin
Forsen Monica
Savolainen Satu
Marjanen Tapani
References (48)
48 references, click to expand
  1. Insulin resistance syndrome revisited: application of self-organizing maps.
    Int J Epidemiol. 2002 Aug;31(4):864-71 PMID: 12177035
  2. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
    Diabetes Care. 2007 May;30(5):1248-54 PMID: 17303788
  3. Relationship between lipid profiles and kidney function in patients with type 1 diabetes.
    Diabetologia. 2008 Jan;51(1):12-20 PMID: 17994214
  4. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients.
    Diabetologia. 2003 Oct;46(10):1402-7 PMID: 12928771
  5. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
    Diabetes. 2000 Sep;49(9):1399-408 PMID: 10969821
  6. Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes.
    Diabetologia. 2001 Sep;44 Suppl 2:S46-53 PMID: 11587050
  7. Incidence of end-stage renal disease in patients with type 1 diabetes.
    JAMA. 2005 Oct 12;294(14):1782-7 PMID: 16219881
  8. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy.
    Diabetes Care. 2007 May;30(5):1162-7 PMID: 17337502
  9. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration.
    Clin Endocrinol (Oxf). 2006 Dec;65(6):776-82 PMID: 17121530
  10. Application of self-organizing maps in conformational analysis of lipids.
    J Am Chem Soc. 2001 Feb 7;123(5):810-6 PMID: 11456614
  11. Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study.
    Diabetes. 2005 Apr;54(4):1238-44 PMID: 15793268
  12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
    Circulation. 2002 Dec 17;106(25):3143-421 PMID: 12485966
  13. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.
    Diabetes Care. 2007 Oct;30(10):2706-7 PMID: 17620444
  14. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.
    Diabetologia. 2005 Sep;48(9):1911-8 PMID: 16078018
  15. A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data.
    BMC Bioinformatics. 2007 May 03;8 Suppl 2:S8 PMID: 17493257
  16. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.
    Diabetes. 2008 Jan;57(1):218-28 PMID: 17914031
  17. Integration of transcriptomics and metabolomics for understanding of global responses to nutritional stresses in Arabidopsis thaliana.
    Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10205-10 PMID: 15199185
  18. Diabetic nephropathy: diagnosis, prevention, and treatment.
    Diabetes Care. 2005 Jan;28(1):164-76 PMID: 15616252
  19. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Invest Ophthalmol Vis Sci. 2004 Mar;45(3):910-8 PMID: 14985310
  20. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.
    Nat Clin Pract Endocrinol Metab. 2005 Dec;1(2):100-10 PMID: 16929378
  21. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes.
    Diabetes Care. 2001 Dec;24(12):2071-7 PMID: 11723085
  22. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Curr Opin Lipidol. 2007 Jun;18(3):263-70 PMID: 17495599
  23. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.
    Am J Epidemiol. 2003 Apr 15;157(8):701-11 PMID: 12697574
  24. Highly elevated serum phyto-oestrogen concentrations in patients with diabetic nephropathy.
    J Intern Med. 2004 May;255(5):602-9 PMID: 15078503
  25. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.
    Diabetologia. 2005 Jun;48(6):1088-92 PMID: 15875155
  26. Systematic review on urine albumin testing for early detection of diabetic complications.
    Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163 PMID: 16095545
  27. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.
    Diabetes. 2006 Nov;55(11):3166-74 PMID: 17065357
  28. Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus.
    J Clin Endocrinol Metab. 2006 Oct;91(10):3814-20 PMID: 16882744
  29. Determinants of serum adiponectin in persons with and without type 1 diabetes.
    Am J Epidemiol. 2007 Sep 15;166(6):731-40 PMID: 17591595
  30. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
    J Diabetes Complications. 2005 Jul-Aug;19(4):223-32 PMID: 15993357
  31. Assays for the functional activity of the mannan-binding lectin pathway of complement activation.
    Immunobiology. 2002 Sep;205(4-5):446-54 PMID: 12396006
  32. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.
    Diabetologia. 2001 Sep;44 Suppl 2:S14-21 PMID: 11587045
  33. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy.
    Diabetologia. 2005 Jan;48(1):198-202 PMID: 15616805
  34. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
    Diabetes Care. 2004 Feb;27(2):530-7 PMID: 14747240
  35. 1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps.
    NMR Biomed. 2007 Nov;20(7):658-72 PMID: 17212341
  36. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).
    Diabetes Care. 2005 Aug;28(8):2019-24 PMID: 16043748
  37. Screening for chronic kidney disease in patients with diabetes: are we missing the point?
    Nat Clin Pract Nephrol. 2008 Jan;4(1):2-3 PMID: 18043592
  38. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.
    Diabetes. 2004 Jul;53(7):1773-81 PMID: 15220201
  39. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death.
    Mol Syst Biol. 2008;4:167 PMID: 18277383
  40. Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q.
    Kidney Int. 2007 Jan;71(2):140-5 PMID: 17021601
  41. Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.
    Atherosclerosis. 2008 Apr;197(2):868-76 PMID: 17888929
  42. The metabolic syndrome.
    Lancet. 2005 Apr 16-22;365(9468):1415-28 PMID: 15836891
  43. Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.
    MAGMA. 2006 Dec;19(6):281-96 PMID: 17171386
  44. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
    JAMA. 2001 Jul 11;286(2):180-7 PMID: 11448281
  45. Serum adiponectin is increased in type 1 diabetic patients with nephropathy.
    Diabetes Care. 2005 Jun;28(6):1410-4 PMID: 15920060
  46. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.
    Mol Syst Biol. 2007;3:124 PMID: 17625512
  47. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
    Ann Med. 2006;38(5):322-36 PMID: 16938802
  48. Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients.
    Diabet Med. 2005 Jun;22(6):723-9 PMID: 15910623
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
1939-327X
Published
2008-09-00
Epub
2008-00-10
Pages
2480-7
Language
English
Region
United States
NLM ID
0372763
PMCID
PMC2518500
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com